189 related articles for article (PubMed ID: 17971165)
1. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
Hallinan R; Byrne A; Agho K; McMahon CG; Tynan P; Attia J
Int J Androl; 2009 Apr; 32(2):131-9. PubMed ID: 17971165
[TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment.
Hallinan R; Byrne A; Agho K; McMahon C; Tynan P; Attia J
J Sex Med; 2008 Mar; 5(3):684-92. PubMed ID: 18093096
[TBL] [Abstract][Full Text] [Related]
3. Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.
Yee A; Loh HS; Danaee M; Riahi S; Ng CG; Sulaiman AH
J Sex Med; 2018 Feb; 15(2):159-166. PubMed ID: 29275046
[TBL] [Abstract][Full Text] [Related]
4. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
[TBL] [Abstract][Full Text] [Related]
5. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
6. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence.
Bliesener N; Albrecht S; Schwager A; Weckbecker K; Lichtermann D; Klingmüller D
J Clin Endocrinol Metab; 2005 Jan; 90(1):203-6. PubMed ID: 15483091
[TBL] [Abstract][Full Text] [Related]
7. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
8. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
[TBL] [Abstract][Full Text] [Related]
10. Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
Nielsen S; Dietze P; Cantwell K; Lee N; Taylor D
J Subst Abuse Treat; 2008 Dec; 35(4):457-61. PubMed ID: 18295435
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Loeber S; Kniest A; Diehl A; Mann K; Croissant B
Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
[TBL] [Abstract][Full Text] [Related]
12. [Buprenorphine and methadone to opiate addicts--a randomized trial].
Kristensen Ø; Espegren O; Asland R; Jakobsen E; Lie Ø; Seiler S
Tidsskr Nor Laegeforen; 2005 Jan; 125(2):148-51. PubMed ID: 15665884
[TBL] [Abstract][Full Text] [Related]
13. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
14. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
15. Comparing overdose mortality associated with methadone and buprenorphine treatment.
Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
[TBL] [Abstract][Full Text] [Related]
16. [The impact of substitution treatment by methadone among opiate-dependent subjects evaluated by Addiction Severity Index and by urine tests].
Trémeau F; Darreye A; Khidichian F; Weibel H; Kempf M; Greth P; Schneider JL; Wantz C; Weber B; Stépien S; Macher JP
Encephale; 2002; 28(5 Pt 1):448-53. PubMed ID: 12386547
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Winstock AR; Lea T; Sheridan J
Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. Relative androgen deficiency in relation to obesity and metabolic status in older men.
Chen RY; Wittert GA; Andrews GR
Diabetes Obes Metab; 2006 Jul; 8(4):429-35. PubMed ID: 16776750
[TBL] [Abstract][Full Text] [Related]
20. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
Whitham JN; Spurrier NJ; Sawyer MG; Baghurst PA; Taplin JE; White JM; Gordon AL
Neurotoxicol Teratol; 2010; 32(2):280-8. PubMed ID: 19751825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
